4882.T JPX
Perseus Proteomics Inc.
1W: -5.8%
1M: +11.8%
3M: +1.3%
YTD: -32.4%
1Y: -60.3%
3Y: -42.3%
5Y: -79.9%
¥166.00 ($1.05)
+5.00 (+3.11%)
Weekly Expected Move ±7.8%
¥136
¥148
¥161
¥174
¥186
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$1.8B
+7.4% ▲
5Y CAGR: +27.2%
Total Liabilities
$386M
+30.8% ▲
5Y CAGR: +52.6%
Shareholders Equity
$1.4B
+2.4% ▲
5Y CAGR: +24.2%
Cash & Investments
$1.7B
+8.2% ▲
5Y CAGR: +28.2%
Total Debt
$0
+0.0% ▲
Net Debt
-$1.7B
-8.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.1B | $3.2B | $2.4B | $1.5B | $1.7B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $1.1B | $3.2B | $2.4B | $1.5B | $1.7B |
| Net Receivables | $31M | $45M | $51M | $84M | $73M |
| Inventory | $2M | $3M | $3M | $4M | $5M |
| Other Current Assets | $2M | $215K | $13K | $13M | $16M |
| Total Current Assets | $1.1B | $3.3B | $2.5B | $1.7B | $1.8B |
| Property, Plant & Equip. | $0 | $0 | $0 | $0 | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $9M | $9M | $51M | $42M | $42M |
| Other Non-Current Assets | $724K | $724K | $658K | $863K | $863K |
| Total Non-Current Assets | $10M | $10M | $52M | $43M | $43M |
| Total Assets | $1.1B | $3.3B | $2.6B | $1.7B | $1.8B |
| — Liabilities — | |||||
| Accounts Payable | $22M | $115M | $0 | $1M | $61M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $14M | $110M | $128M | $46M |
| Total Current Liabilities | $35M | $148M | $111M | $129M | $125M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $1K | $1K | $59M | $166M | $262M |
| Total Non-Current Liabilities | $1K | $1K | $59M | $166M | $262M |
| Total Liabilities | $35M | $148M | $170M | $295M | $386M |
| — Equity — | |||||
| Common Stock | $604M | $1.9B | $1.9B | $2.0B | $2.4B |
| Retained Earnings | -$413M | -$1.0B | -$1.8B | -$2.9B | -$3.8B |
| Accumulated OCI | $3M | $0 | $31M | $74M | $79M |
| Total Stockholders Equity | $1.1B | $3.2B | $2.4B | $1.4B | $1.4B |
| Total Liabilities & Equity | $1.1B | $3.3B | $2.6B | $1.7B | $1.8B |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$1.1B | -$3.2B | -$2.4B | -$1.5B | -$1.7B |
| Total Investments | $9M | $9M | $51M | $42M | $42M |